A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults

Clinical trial NCT06237049 · COMPLETED

Trial details

NCT number: NCT06237049
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza, Human SARS-CoV-2 Infection COVID-19

Start date: 2024-01-31
Primary completion: 2024-09-13
Enrollment: 644

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.